Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

China study says Wuhan COVID infections 3 times higher than official figure

Published 01/07/2021, 10:18 PM
Updated 01/07/2021, 10:20 PM
© Reuters. FILE PHOTO: Exhibition on China's fight against the coronavirus disease (COVID-19) outbreak in Wuhan

SHANGHAI (Reuters) - The number of people who have been infected with COVID-19 in the Chinese city of Wuhan, where the virus was first identified, could be around three times the official figure, according to a study by Chinese researchers based in the city.

The paper, published by the PLOS Neglected Tropical Diseases journal on Thursday, analysed blood samples from more than 60,000 healthy individuals taken from locations across China from March to May 2020.

It found that 1.68% of those from Wuhan contained antibodies for SARS-CoV-2, the virus that causes COVID-19, compared to 0.59% in surrounding Hubei province and 0.38% in the rest of China.

With the city's total population at more than 10 million, the researchers estimated that as many as 168,000 Wuhan residents were infected with the virus, compared to the official number of 50,340 hospitalised cases.

The study suggested at least two thirds of the total number were asymptomatic, and thousands could have been infected after the "elimination" of clinical cases, raising the possibility the virus could exist in a community for a long period without causing hospitalisations.

A separate study published by the Chinese Center for Disease Control and Prevention (CDC) late last month put the "seroprevalence" rate in Wuhan, the percentage of the population with antibodies, even higher at 4.43%, implying that around half a million people in the city could have been infected.

COVID-19 was identified in Wuhan at the end of 2019, with the first outbreak associated with a seafood market in the city. China finally locked down Wuhan and other cities in Hubei province on Jan. 23, 2020, but critics say it should have acted sooner.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

China has dismissed criticism of its early handling of the virus, and officials now point to overseas studies suggesting it was circulating in Europe several months before the Wuhan outbreak.

A 10-strong team from the World Health Organization was due to arrive in China this week to investigate the origins of COVID-19, but they have yet to be been given authorisation to enter the country.

Total number of confirmed COVID-19 cases to date in mainland China now stands at 87,331, while the death toll remained unchanged at 4,634.

Latest comments

Good ole Commies. Sure we believe. China needs reckoned
"China officials now point to overseas studies suggesting it was circulating in Europe several months before the Wuhan outbreak." Riiiight... China doing what it wants, doesn't care about the truth. typical
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.